liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Proteome of Coxiella burnetii
Linköping University, Department of Clinical and Experimental Medicine, Cell Biology. Linköping University, Faculty of Health Sciences.ORCID iD: 0000-0001-5751-3622
Dep. Microbiology and Molecular Genetics, Oklahoma State University, USA.
Institute of Virology, Slovak Academy of Science, Bratislava, Slovakia.
2012 (English)In: Coxiella burnetii: Recent Advances and New Perspectives in Research of the Q Fever Bacterium / [ed] Rudolf Toman, Robert A. Heinzen, James E. Samuel and Jean-Louis Mege, Springer-Verlag New York, 2012, Vol. 984, p. 105-130Chapter in book (Refereed)
Abstract [en]

Recent proteomic studies of C. burnetii, the etiological agent of Q fever, have brought a deeper insight into the pathogens physiology and offered new possibilities in investigations of inter- or intra-species relatedness. The data generated from these studies in conjunction with the current genomic sequence databases may reveal additional identities for conserved and unique C. burnetii biomarkers and aid in creating algorithms and/or databases that could develop into diagnostic and detection tools for the pathogen. Moreover, wide scale screening and further characterization of potential C. burnetii protein antigens along with a comprehensive evaluation of the humoral immune response will be of fundamental importance towards research and development of a safe and efficacious vaccine as well as improved serodiagnostic tests for rapid and sensitive detection of the Q fever pathogen. Given these advances, proteomics may make marked contributions to the improvement of human health protection against C. burnetii in the coming years.

Place, publisher, year, edition, pages
Springer-Verlag New York, 2012. Vol. 984, p. 105-130
Series
Advances in Experimental Medicine and Biology, ISSN 0065-2598, E-ISSN 2214-8019 ; 984
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:liu:diva-80251DOI: 10.1007/978-94-007-4315-1_6ISI: 000333215000007PubMedID: 22711629ISBN: 9789400743144 (print)ISBN: 9789400743151 (electronic)ISBN: 9789400792050 (print)OAI: oai:DiVA.org:liu-80251DiVA, id: diva2:546322
Available from: 2012-08-23 Created: 2012-08-23 Last updated: 2018-03-05Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Ihnatko, Robert

Search in DiVA

By author/editor
Ihnatko, Robert
By organisation
Cell BiologyFaculty of Health Sciences
Microbiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
isbn
urn-nbn

Altmetric score

doi
pubmed
isbn
urn-nbn
Total: 4526 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf